Shang-Jui Wang

Shang-Jui Wang is a radiation oncologist whose research spans clinical treatment strategies for cancers such as bladder, lung, rectal, and skin cancers, along with laboratory studies on how the p53 tumor-suppressor gene helps control cell death and metabolism. The work combines multi-institutional clinical trials on radiotherapy and chemoradiation approaches with molecular biology research into cancer biomarkers and treatment resistance mechanisms.

Publication output has grown over the last decade, rising from occasional papers earlier on to a peak of 10 in 2020, with continued strong and somewhat variable activity (including 10 in 2025) through 2026.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026